Golbe, Jesus L.

HRN: 23-52-99  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2023
CEFTRIAXONE 1G (VIAL)
08/15/2023
08/21/2023
IVT
2g
OD
T/c Sepsis
Waiting Final Action 
08/16/2023
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
08/16/2023
08/22/2023
OINTMENT
0.5
Bid
Eye Infection
Waiting Final Action 
08/16/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/16/2023
08/22/2023
IV
600
Q8
Orbital Cellulitis
Waiting Final Action 
08/16/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/16/2023
08/22/2023
IV
600mg
Q6
Orbital Cellulitis
Waiting Final Action 
08/19/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/19/2023
08/25/2023
IV
600mg
Q8
Cavernous Sinus Thrombosis
Waiting Final Action 
08/19/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/19/2023
08/25/2023
IV
1.5
Q6
Cavernous Sinus Thrombosis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: